Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market buy Chief Marketing Officer bought 12,800 shares at $20.83 ($266,591)
  2. 4 Open-market sale 10% owner sold 1,750,000 shares at $21.04 ($36,820,000)
  3. 4 Open-market buy Director bought 10,000 shares at $19.83 ($198,270)
  4. 4 Open-market sale 10% owner sold 1,000,000 shares at $18.80 ($18,800,000)
  5. 4 Grant or award Chief Marketing Officer acquired 50,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 8,600 shares at $28.88 ($248,353)
  8. 4 Open-market buy Director bought 2,200 shares at an average $28.54 ($62,780)
  9. 4 Open-market buy Director bought 2,898 shares at $34.94 ($101,256)
  10. 4 Open-market buy Director bought 7,142 shares at $29.19 ($208,471)
  11. 4 Open-market buy Director bought 7,000 shares at an average $25.16 ($176,148)
  12. 4 Grant or award SILVERNAIL LAUREN P acquired 30,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 13 · 252 filings